We Love Fitness

new warnings for ms drug gilenya after fda review

Novartis, the maker of the drug Gilenya (fingolimod), a once-daily oral capsule taken for multiple sclerosis, has added stronger warnings to labels and prescription information about the drug’s possible heart risks, according to a company statement.


 Articles & News
We Love Fitness - 2013